← Scroll for more →
KalVista Pharmaceuticals, Inc. (KALV)
Pharmaceutical Preparations
Latest Price
$27.00
TTM P/E
--
Normalized P/E
--
TTM Div Yield
--
Fwd Div Yield
--
Book Value
0.76
P/B Ratio
35.41
Institutional Ownership
100.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Venrock Adviser, LLC | 6.47M | $130.0M | 12.64% | -254.5K | 2026-03-31 |
| Frazier Life Sciences Management, L.P. | 4.96M | $99.0M | 9.68% | -78.8K | 2026-03-31 |
| Montanova Capital, LLC | 4.77M | $95.0M | 9.31% | -- | 2026-03-31 |
| Tang Capital Management LLC | 4.57M | $92.0M | 8.93% | -- | 2026-03-31 |
| BlackRock, Inc. | 3.80M | $76.0M | 7.41% | +41.7K | 2026-03-31 |
| Silverarc Capital Management, LLC | 2.88M | $57.0M | 5.61% | +449.3K | 2026-03-31 |
| Capital World Investors | 2.81M | $56.0M | 5.48% | -- | 2026-03-31 |
| Caption Management, LLC | 2.43M | $48.0M | 4.74% | +2.31M | 2026-03-31 |
| Point72 Asset Management, L.P. | 2.14M | $43.0M | 4.17% | -146.8K | 2026-03-31 |
| State Street Corp | 1.96M | $39.0M | 3.82% | +44.2K | 2026-03-31 |